XERIANT, INC.
For the period ended Dec 31, 2025. Filed Feb 17, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2025 · Filed Feb 17, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Unregistered Sales of Equity Securities
During the six month period ended December 31, 2025, the Company issued 8,256,410 shares for various services, 72,000,000 shares from conversion of Series A Preferred stock, 56,760,000 shares for conversion of principal and accrued interest, and 30,000,000 shares issued in connection with the Auctus Settlement. The Company believes that the issuance of the securities was exempt from registration under the Securities Act of 1933, as amended, in reliance on Section 4(2) of the Securities Act as a transaction by an issuer not involving any public offering and based on the fact that such securities were issued for services to sophisticated or accredited investors and persons who are thoroughly familiar with the Company’s proposed business by virtue of their affiliation with the Company.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.